Which autoimmune diseases are most common
Diabetes Obes Metab 2013
however, severe or persistent symptoms, such as severe pain, vomiting, or jaundice, require prompt medical attention
FDA applies four factors to determine whether a compounded drug is essentially a copy of a commercially available product: Same active ingredient semaglutide or tirzepatide Same route of administration subcutaneous injection Same dosage form injectable solution Same strength matching FDA-approved doses (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg, etc.) If your compounded product meets these four criteria, it is essentially a copy of Ozempic, Wegovy, Mounjaro, or Zepbound and it is illegal to compound, prescribe, or dispense
Clinically, that 5% mark is meaningful: its commonly used as a benchmark for whether a medication is providing benefit, not as a final outcome